Morgan Stanley (NYSE:MS) analyst Ricky Goldwasser maintained a Buy rating on Centene (NYSE:CNC) on Friday, setting a price target of $109, which is approximately 31.33% above the present share price of $83.
Goldwasser expects Centene to post earnings per share (EPS) of $1.00 for the fourth quarter of 2021.
The current consensus among 14 TipRanks analysts is for a Moderate Buy rating of shares in Centene, with an average price target of $89.79.
The analysts price targets range from a high of $109 to a low of $78.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $32.41 billion and a net profit of $774 million. The company's market cap is $48.43 billion.
According to TipRanks.com, Morgan Stanley analyst Ricky Goldwasser is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 15.6% and a 66.43% success rate.
Centene Corporation is a diversified healthcare company that primarily engages in providing programs and services to the government sponsored healthcare programs. The company is also engaged in providing education and outreach programs to assist members in accessing quality and appropriate healthcare services.